Molecule Holdings (CNSX:MLCL) - Aandelenkoers, Nieuws & Analyse

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

MLCL Overzicht aandelen

Engages in production and co-packing of cannabis-infused beverages in Canada.

MLCL fundamentele analyse
Sneeuwvlok Score
Waardering	0/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	0/6
Dividenden	0/6

Beloningen

Risicoanalyse

Negatief eigen vermogen

De winst is de afgelopen 5 jaar met 20.4% per jaar gedaald

Aandelen zijn zeer illiquide

Heeft geen betekenisvolle marktkapitalisatie ( CA$489K )

+ 1 meer risico

Molecule Holdings Inc. Concurrenten

Hempsana Holdings

CNSX:HMPS

CA$591.3k

SugarBud Craft Growers

TSXV:SUGR.H

CA$718.6k

West Island Brands

CNSX:WIB

CA$2.0m

Steep Hill

CNSX:STPH

CA$404.5k

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Molecule Holdings
Historische aandelenkoersen
Huidige aandelenkoers	CA$0
52 Week Hoogtepunt	CA$0.015
52 Week Laag	CA$0.005
Bèta	-0.78
11 maand verandering	n/a
3 maanden verandering	n/a
1 Jaar Verandering	n/a
33 jaar verandering	n/a
5 jaar verandering	n/a
Verandering sinds IPO	n/a

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	MLCL	CA Pharmaceuticals	CA Markt
7D	n/a	3.6%	1.4%
1Y	n/a	9.8%	27.4%

Rendement versus industrie: Er zijn onvoldoende gegevens om te bepalen hoe MLCL presteerde ten opzichte van de Canadian Pharmaceuticals.

Rendement versus markt: Er zijn onvoldoende gegevens om te bepalen hoe MLCL presteerde ten opzichte van de Canadian markt.

Prijsvolatiliteit

Is MLCL's price volatile compared to industry and market?
MLCL volatility
MLCL Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.1%
Market Average Movement	8.2%
10% most volatile stocks in CA Market	17.3%
10% least volatile stocks in CA Market	3.0%

Stabiele aandelenkoers: MLCL heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: Onvoldoende gegevens om de volatiliteitsverandering van MLCL in het afgelopen jaar te bepalen.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
n/a	n/a	David Reingold	molecule.ca

Molecule Holdings Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Molecule Holdings zich tot de beurswaarde?
MLCL fundamentele statistieken
Marktkapitalisatie	CA$488.91k
Inkomsten(TTM)	-CA$3.45m
Inkomsten(TTM)	CA$1.78m

0.0x

P/S-verhouding

0.0x

Koers/Winstverhouding

Is MLCL overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
MLCL resultatenrekening (TTM)
Inkomsten	CA$1.78m
Kosten van inkomsten	CA$2.23m
Brutowinst	-CA$449.70k
Overige uitgaven	CA$3.01m
Inkomsten	-CA$3.45m

Laatst gerapporteerde inkomsten

Jul 31, 2023

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.035
Brutomarge	-25.27%
Nettowinstmarge	-194.18%
Schuld/Eigen Vermogen Verhouding	-102.3%

Hoe presteerde MLCL op de lange termijn?

Bekijk historische prestaties en vergelijking

MLCL Overzicht aandelen

Beloningen

Risicoanalyse

Molecule Holdings Inc. Concurrenten

CNSX:HMPS

CA$591.3k

TSXV:SUGR.H

CA$718.6k

CNSX:WIB

CA$2.0m

CNSX:STPH

CA$404.5k

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Less than half of directors are independent

Molecule Holdings Inc. Announces Change of Chief Financial Officer

Second quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.009 loss in 2Q 2022)

New major risk - Revenue and earnings growth

Less than half of directors are independent

Molecule Holdings Inc. (CNSX:MLCL) has entered into a non-binding letter of intent to acquire Canna-Day Development Inc. from the shareholders of Canna-Day for CAD 0.75 million.

Recent updates

Less than half of directors are independent

Molecule Holdings Inc. Announces Change of Chief Financial Officer

Second quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.009 loss in 2Q 2022)

New major risk - Revenue and earnings growth

Less than half of directors are independent

Molecule Holdings Inc. (CNSX:MLCL) has entered into a non-binding letter of intent to acquire Canna-Day Development Inc. from the shareholders of Canna-Day for CAD 0.75 million.

Molecule Holdings Inc. (CNSX:MLCL) has entered into a non-binding letter of intent to acquire Canna-Day Development Inc. from the shareholders of Canna-Day for CAD 0.75 million.

Molecule Holdings Inc. Launches New Products

Molecule Holdings Inc. Announces Embody Launch in British Columbia

Molecule Holdings Inc. announced that it expects to receive CAD 3 million in funding

Molecule Holdings Inc. announced that it has received CAD 0.6 million in funding

Less than half of directors are independent

Molecule Holdings Inc. Announces New Skus Available for Purchase Now with OCS

Molecule Holdings Inc., Annual General Meeting, Apr 27, 2022

Molecule Holdings Inc. to Launch Seven New Products in the Ontario Cannabis Store for Spring and Summer

Molecule Holdings Inc. Announces Addition of its Newest Brand Embody

Molecule Holdings Inc. Announces its Newest Lineup of Products Under the Brand Name Canajo

Less than half of directors are independent

Molecule Holdings Inc. announced that it has received CAD 2.434 million in funding

Molecule Holdings Inc. announced that it expects to receive CAD 1.5 million in funding

Molecule Holdings Inc. Announces Availability of the First 5 of Its Beverages for Purchase Online

Molecule Holdings Inc. Launches Phresh Cannabis Beverages for Canadian Summer Beverage Season

Molecule Holdings Inc. announced that it has received CAD 1 million in funding

Molecule Receives Opening Pipeline Orders from Ontario Cannabis Store

Molecule Holdings Inc., Annual General Meeting, Apr 30, 2021

Molecule Holdings Inc. Completes Test Production Run Preceding Health Canada Sales Amendment Application and Inventory Accumulation

Molecule Holdings Inc. Completes Full-Scale Test of Cannabis Beverage Production in its Health Canada Licensed Facility and Submits NNCP for New House Brand "52 Saturdays"

Molecule Holdings Inc. Submits Notice of New Cannabis Product for New House Brand, KLON Beverages

Molecule Signs a Letter of Intent with la Société Québécoise du Cannabis (SQDC)

Molecule Holdings Inc. Signs Cannabis Supply Agreement with ABcann Medicinals Inc

Molecule Holdings Inc. Appoints Jeff Stoss as Chief Financial Officer

Molecule Signs Agreement with Hill Street Beverage Company Inc. to Produce Cannabis Infused Beverages

Molecule Holdings Inc. Signs Binding Term Sheet with Biolux Natural Health Inc

Molecule Inc. completed the acquisition of Everton Resources Inc. (TSXV:EVR) in a reverse merger transaction.

Molecule Holdings Inc. Receives Final Piece of Equipment for Producing Craft Cannabis Beverages

Rendement voor aandeelhouders

Prijsvolatiliteit

Over het bedrijf

Molecule Holdings Inc. Samenvatting

0.0x

0.0x

Inkomsten en omzet